Published in N Engl J Med on June 29, 2009
Mortality from pandemic A/H1N1 2009 influenza in England: public health surveillance study. BMJ (2009) 4.99
Intensive care adult patients with severe respiratory failure caused by Influenza A (H1N1)v in Spain. Crit Care (2009) 4.45
Partial protection of seasonal trivalent inactivated vaccine against novel pandemic influenza A/H1N1 2009: case-control study in Mexico City. BMJ (2009) 4.31
Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: four observational studies from Canada. PLoS Med (2010) 3.85
Clinical findings and demographic factors associated with ICU admission in Utah due to novel 2009 influenza A(H1N1) infection. Chest (2009) 3.70
2009 pandemic influenza A (H1N1): pathology and pathogenesis of 100 fatal cases in the United States. Am J Pathol (2010) 3.32
Risk factors and outcomes among children admitted to hospital with pandemic H1N1 influenza. CMAJ (2009) 3.11
Streptococcus pneumoniae coinfection is correlated with the severity of H1N1 pandemic influenza. PLoS One (2009) 2.65
Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes. Nat Med (2010) 2.59
Excessive neutrophils and neutrophil extracellular traps contribute to acute lung injury of influenza pneumonitis. Am J Pathol (2011) 2.57
Characterizing the epidemiology of the 2009 influenza A/H1N1 pandemic in Mexico. PLoS Med (2011) 2.41
Risk factors for hospitalisation and poor outcome with pandemic A/H1N1 influenza: United Kingdom first wave (May-September 2009). Thorax (2010) 2.36
A modified sequential organ failure assessment score for critical care triage. Disaster Med Public Health Prep (2010) 2.28
Introduction of virulence markers in PB2 of pandemic swine-origin influenza virus does not result in enhanced virulence or transmission. J Virol (2010) 2.19
Virulence-associated substitution D222G in the hemagglutinin of 2009 pandemic influenza A(H1N1) virus affects receptor binding. J Virol (2010) 2.17
p63(+)Krt5(+) distal airway stem cells are essential for lung regeneration. Nature (2014) 2.06
Critically ill patients with 2009 H1N1 infection in an Indian ICU. Indian J Crit Care Med (2010) 2.01
Does Glycosylation as a modifier of Original Antigenic Sin explain the case age distribution and unusual toxicity in pandemic novel H1N1 influenza? BMC Infect Dis (2010) 2.01
Critical illness from 2009 pandemic influenza A virus and bacterial coinfection in the United States. Crit Care Med (2012) 2.00
Modeling host responses in ferrets during A/California/07/2009 influenza infection. Virology (2010) 1.93
Clinical and laboratory features distinguishing pandemic H1N1 influenza-related pneumonia from interpandemic community-acquired pneumonia in adults. Thorax (2011) 1.91
Innate immune responses to influenza A H5N1: friend or foe? Trends Immunol (2009) 1.89
Pathogenesis and transmission of swine origin A(H3N2)v influenza viruses in ferrets. Proc Natl Acad Sci U S A (2012) 1.80
PB1-F2 proteins from H5N1 and 20 century pandemic influenza viruses cause immunopathology. PLoS Pathog (2010) 1.75
Influenza: the once and future pandemic. Public Health Rep (2010) 1.65
Correlation of pandemic (H1N1) 2009 viral load with disease severity and prolonged viral shedding in children. Emerg Infect Dis (2010) 1.64
The effects of influenza A virus PB1-F2 protein on polymerase activity are strain specific and do not impact pathogenesis. J Virol (2010) 1.63
Imaging findings in a fatal case of pandemic swine-origin influenza A (H1N1). AJR Am J Roentgenol (2009) 1.63
Assessment of seasonal influenza A virus-specific CD4 T-cell responses to 2009 pandemic H1N1 swine-origin influenza A virus. J Virol (2010) 1.62
Real time reverse transcription (RRT)-polymerase chain reaction (PCR) methods for detection of pandemic (H1N1) 2009 influenza virus and European swine influenza A virus infections in pigs. Influenza Other Respir Viruses (2010) 1.61
Characteristics and outcome of critically ill patients with 2009 H1N1 influenza infection in Syria. Avicenna J Med (2012) 1.60
Association of 2009 pandemic influenza A (H1N1) infection and increased hospitalization with parapneumonic empyema in children in Utah. Pediatr Infect Dis J (2010) 1.59
Influenza virus primes mice for pneumonia from Staphylococcus aureus. J Infect Dis (2011) 1.56
Rescue therapy in adult and pediatric patients with pH1N1 influenza infection: a tertiary center intensive care unit experience from April to October 2009. Crit Care Med (2010) 1.55
UK newspapers' representations of the 2009-10 outbreak of swine flu: one health scare not over-hyped by the media? J Epidemiol Community Health (2010) 1.49
Comparative age distribution of influenza morbidity and mortality during seasonal influenza epidemics and the 2009 H1N1 pandemic. BMC Infect Dis (2010) 1.48
Pandemic swine-origin H1N1 influenza A virus isolates show heterogeneous virulence in macaques. J Virol (2010) 1.47
Pulmonary imaging of pandemic influenza H1N1 infection: relationship between clinical presentation and disease burden on chest radiography and CT. Br J Radiol (2010) 1.47
Effect of the novel influenza A (H1N1) virus in the human immune system. PLoS One (2009) 1.45
Recipients of vaccine against the 1976 "swine flu" have enhanced neutralization responses to the 2009 novel H1N1 influenza virus. Clin Infect Dis (2010) 1.44
Novel influenza A (H1N1) infection vs. common influenza-like illness: a prospective study. Med Sci Monit (2011) 1.43
Influenza H5N1 and H1N1 virus replication and innate immune responses in bronchial epithelial cells are influenced by the state of differentiation. PLoS One (2010) 1.41
Pulmonary complication of novel influenza A (H1N1) infection: imaging features in two patients. Korean J Radiol (2009) 1.41
Chinese guidelines for diagnosis and treatment of influenza (2011). J Thorac Dis (2011) 1.40
Predictors of clinical outcome in a national hospitalised cohort across both waves of the influenza A/H1N1 pandemic 2009-2010 in the UK. Thorax (2012) 1.40
French experience of 2009 A/H1N1v influenza in pregnant women. PLoS One (2010) 1.35
Age distribution of cases of 2009 (H1N1) pandemic influenza in comparison with seasonal influenza. PLoS One (2011) 1.33
Reducing occurrence and severity of pneumonia due to pandemic H1N1 2009 by early oseltamivir administration: a retrospective study in Mexico. PLoS One (2011) 1.32
Pulmonary sequelae in a patient recovered from swine flu. Lung India (2012) 1.32
Two years after pandemic influenza A/2009/H1N1: what have we learned? Clin Microbiol Rev (2012) 1.31
Possible increased pathogenicity of pandemic (H1N1) 2009 influenza virus upon reassortment. Emerg Infect Dis (2011) 1.31
Inside the outbreak of the 2009 influenza A (H1N1)v virus in Mexico. PLoS One (2010) 1.30
Pandemic (H1N1) 2009 influenza community transmission was established in one Australian state when the virus was first identified in North America. PLoS One (2010) 1.30
Characterization in vitro and in vivo of a pandemic H1N1 influenza virus from a fatal case. PLoS One (2013) 1.30
Epidemiology of human infection with the novel virus influenza A (H1N1) in the Hospital das Clínicas, São Paulo, Brazil--June-September 2009. Clinics (Sao Paulo) (2009) 1.27
Factors associated with death in hospitalized pneumonia patients with 2009 H1N1 influenza in Shenyang, China. BMC Infect Dis (2010) 1.26
Epidemiological characterization of a fourth wave of pandemic A/H1N1 influenza in Mexico, winter 2011-2012: age shift and severity. Arch Med Res (2012) 1.25
Interleukin-6 is a potential biomarker for severe pandemic H1N1 influenza A infection. PLoS One (2012) 1.23
Virus-associated hemophagocytic syndrome as a major contributor to death in patients with 2009 influenza A (H1N1) infection. Crit Care (2011) 1.21
Effect of D222G mutation in the hemagglutinin protein on receptor binding, pathogenesis and transmissibility of the 2009 pandemic H1N1 influenza virus. PLoS One (2011) 1.21
Mutations in PA, NP, and HA of a pandemic (H1N1) 2009 influenza virus contribute to its adaptation to mice. Virus Res (2011) 1.21
A retrospective cohort pilot study to evaluate a triage tool for use in a pandemic. Crit Care (2009) 1.21
Comparison of combined nose-throat swabs with nasopharyngeal aspirates for detection of pandemic influenza A/H1N1 2009 virus by real-time reverse transcriptase PCR. J Clin Microbiol (2010) 1.20
Pandemic influenza (H1N1) 2009 pneumonia: CURB-65 score for predicting severity and nasopharyngeal sampling for diagnosis are unreliable. PLoS One (2010) 1.19
Genetic variants associated with severe pneumonia in A/H1N1 influenza infection. Eur Respir J (2011) 1.17
Hospital triage system for adult patients using an influenza-like illness scoring system during the 2009 pandemic--Mexico. PLoS One (2010) 1.17
The role of infections and coinfections with newly identified and emerging respiratory viruses in children. Virol J (2012) 1.17
Situational awareness and health protective responses to pandemic influenza A (H1N1) in Hong Kong: a cross-sectional study. PLoS One (2010) 1.16
Yield of sputum for viral detection by reverse transcriptase PCR in adults hospitalized with respiratory illness. J Clin Microbiol (2011) 1.16
Serial evaluation of high-resolution CT findings in patients with pneumonia in novel swine-origin influenza A (H1N1) virus infection. Br J Radiol (2011) 1.16
The influence of social-cognitive factors on personal hygiene practices to protect against influenzas: using modelling to compare avian A/H5N1 and 2009 pandemic A/H1N1 influenzas in Hong Kong. Int J Behav Med (2011) 1.15
Distinguishing characteristics between pandemic 2009-2010 influenza A (H1N1) and other viruses in patients hospitalized with respiratory illness. PLoS One (2011) 1.15
Thoracic computerized tomographic (CT) findings in 2009 influenza A (H1N1) virus infection in Isfahan, Iran. J Res Med Sci (2011) 1.15
Synergistic inflammation is induced by blood degradation products with microbial Toll-like receptor agonists and is blocked by hemopexin. J Infect Dis (2010) 1.14
The first influenza pandemic of the new millennium. Influenza Other Respir Viruses (2011) 1.14
2009 pandemic H1N1 influenza virus elicits similar clinical course but differential host transcriptional response in mouse, macaque, and swine infection models. BMC Genomics (2012) 1.13
Estimates of the true number of cases of pandemic (H1N1) 2009, Beijing, China. Emerg Infect Dis (2010) 1.13
The novel influenza A (H1N1) virus pandemic: An update. Ann Thorac Med (2009) 1.10
Hospitalized patients with 2009 H1N1 influenza infection: the Mayo Clinic experience. Mayo Clin Proc (2010) 1.10
A single-amino-acid substitution in the HA protein changes the replication and pathogenicity of the 2009 pandemic A (H1N1) influenza viruses in vitro and in vivo. Virol J (2010) 1.09
Glycan shielding of the influenza virus hemagglutinin contributes to immunopathology in mice. Am J Respir Crit Care Med (2010) 1.09
Age-related sensitivity and pathological differences in infections by 2009 pandemic influenza A (H1N1) virus. Virol J (2011) 1.09
Severe pandemic H1N1 2009 infection is associated with transient NK and T deficiency and aberrant CD8 responses. PLoS One (2012) 1.09
Modifications in the polymerase genes of a swine-like triple-reassortant influenza virus to generate live attenuated vaccines against 2009 pandemic H1N1 viruses. J Virol (2010) 1.09
Epidemiology and clinical characteristics of hospitalized patients with pandemic influenza A (H1N1) 2009 infections: the effects of bacterial coinfection. Virol J (2011) 1.08
Toll-like receptor pre-stimulation protects mice against lethal infection with highly pathogenic influenza viruses. Virol J (2011) 1.06
Modeling the critical care demand and antibiotics resources needed during the Fall 2009 wave of influenza A(H1N1) pandemic. PLoS Curr (2009) 1.06
Integrated clinical, pathologic, virologic, and transcriptomic analysis of H5N1 influenza virus-induced viral pneumonia in the rhesus macaque. J Virol (2012) 1.05
Epidemiological aspects of 2009 H1N1 influenza: the accumulating experience from the Northern Hemisphere. Eur J Clin Microbiol Infect Dis (2010) 1.05
Feasibility of inter-hospital transportation using extra-corporeal membrane oxygenation (ECMO) support of patients affected by severe swine-flu(H1N1)-related ARDS. Scand J Trauma Resusc Emerg Med (2011) 1.05
Recrudescent wave of pandemic A/H1N1 influenza in Mexico, Winter 2011-2012: Age shift and severity. PLoS Curr (2012) 1.05
Pathology and viral antigen distribution of lethal pneumonia in domestic cats due to pandemic (H1N1) 2009 influenza A virus. Vet Pathol (2010) 1.03
H1N1-infected Patients in ICU and Their Clinical Outcome. N Am J Med Sci (2012) 1.02
Pandemic and post-pandemic influenza A (H1N1) infection in critically ill patients. Crit Care (2011) 1.01
Estimate of Novel Influenza A/H1N1 cases in Mexico at the early stage of the pandemic with a spatially structured epidemic model. PLoS Curr (2009) 1.01
Pandemic 2009 influenza A (H1N1) infection among 2009 Hajj Pilgrims from Southern Iran: a real-time RT-PCR-based study. Influenza Other Respir Viruses (2012) 0.99
Low clinical burden of 2009 pandemic influenza A (H1N1) infection during pregnancy on the island of La Réunion. PLoS One (2010) 0.99
Serial histopathological examination of the lungs of mice infected with influenza A virus PR8 strain. PLoS One (2011) 0.99
Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl J Med (2010) 9.90
Critically Ill patients with 2009 influenza A(H1N1) in Mexico. JAMA (2009) 9.41
Severe respiratory disease concurrent with the circulation of H1N1 influenza. N Engl J Med (2009) 8.99
Idiopathic pulmonary fibrosis and emphysema: decreased survival associated with severe pulmonary arterial hypertension. Chest (2009) 3.42
COPD phenotypes in biomass smoke- versus tobacco smoke-exposed Mexican women. Eur Respir J (2013) 2.81
Effects of an anti-TSLP antibody on allergen-induced asthmatic responses. N Engl J Med (2014) 2.53
Lung volume reduction surgery in canine model of predominantly upper lobe emphysema: advantages of new surgical system. Chest (2004) 1.49
Reducing occurrence and severity of pneumonia due to pandemic H1N1 2009 by early oseltamivir administration: a retrospective study in Mexico. PLoS One (2011) 1.32
Strong human endogenous retrovirus-specific T cell responses are associated with control of HIV-1 in chronic infection. J Virol (2011) 1.19
APOBEC3G mRNA expression in exposed seronegative and early stage HIV infected individuals decreases with removal of exposure and with disease progression. Retrovirology (2009) 1.08
Unique features of HLA-mediated HIV evolution in a Mexican cohort: a comparative study. Retrovirology (2009) 1.04
Geographic differences in clinical characteristics and management of COPD: the EPOCA study. Int J Chron Obstruct Pulmon Dis (2008) 0.98
Pandemic influenza A/H1N1 virus infection and TNF, LTA, IL1B, IL6, IL8, and CCL polymorphisms in Mexican population: a case-control study. BMC Infect Dis (2012) 0.98
National prevalence and trends of HIV transmitted drug resistance in Mexico. PLoS One (2011) 0.96
Life-threatening exacerbation of Kaposi's sarcoma after prednisone treatment for immune reconstitution inflammatory syndrome. AIDS (2008) 0.96
Population pharmacokinetic/pharmacodynamic model of subcutaneous adipose 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) activity after oral administration of AMG 221, a selective 11β-HSD1 inhibitor. J Clin Pharmacol (2010) 0.93
Severe 2009 pandemic influenza A (H1N1) infection and increased mortality in patients with late and advanced HIV disease. AIDS (2011) 0.92
Microbiological implications of periurban agriculture and water reuse in Mexico City. PLoS One (2008) 0.90
A (H1N1) pdm09 HA D222 variants associated with severity and mortality in patients during a second wave in Mexico. Virol J (2013) 0.89
Molecular characterization of the predominant influenza A(H1N1)pdm09 virus in Mexico, December 2011-February 2012. PLoS One (2012) 0.89
Pulmonary embolism as a cause of death in patients with heart disease: an autopsy study. Chest (2006) 0.88
[Biologic therapies in the systemic vasculitides]. Reumatol Clin (2011) 0.88
Practical lessons from the first outbreaks: clinical presentation, obstacles, and management strategies for severe pandemic (pH1N1) 2009 influenza pneumonitis. Crit Care Med (2010) 0.88
Angiogenic and inflammatory markers in acute respiratory distress syndrome and renal injury associated to A/H1N1 virus infection. Exp Mol Pathol (2013) 0.88
Inflammatory profiles in severe pneumonia associated with the pandemic influenza A/H1N1 virus isolated in Mexico City. Autoimmunity (2011) 0.87
Dissociation of CD154 and cytokine expression patterns in CD38+ CD4+ memory T cells in chronic HIV-1 infection. J Acquir Immune Defic Syndr (2010) 0.86
Urban PM2.5 induces ROS generation and RBC damage in COPD patients. Front Biosci (Elite Ed) (2011) 0.85
H1N1 Influenza Pandemic of 2009 Compared With Other Influenza Pandemics: Epidemiology, Diagnosis, Management, Pulmonary Complications, and Outcomes. Curr Infect Dis Rep (2010) 0.83
Gene expression profiles normalized in psoriatic skin by treatment with brodalumab, a human anti-IL-17 receptor monoclonal antibody. J Immunol (2014) 0.83
Morphologic diversity of chronic pigeon breeder's disease: clinical features and survival. Respir Med (2010) 0.83
Blood pH level modulates organ metabolism of lactate in septic shock in dogs. J Crit Care (2002) 0.82
Urban PM2.5 activates GAPDH and induces RBC damage in COPD patients. Front Biosci (Schol Ed) (2013) 0.82
[Diffuse alveolar hemorrhage: Causes and outcomes in a referral center]. Reumatol Clin (2010) 0.82
Unexpected immunoresponse to Gal and APA antigens in diabetic type 1 patients receiving neonatal pig islets after 6 years. J Clin Immunol (2007) 0.79
Improved method for isolation of porcine neonatal pancreatic cell clusters. Xenotransplantation (2005) 0.79
[Massive pulmonary embolism, thrombus in transit, and right ventricular dysfunction]. Arch Cardiol Mex (2007) 0.78
Thalamic and mesencephalic hemorrhages after multiple honeybee stings: a life-threatening apitherapy complication. Eur Neurol (2003) 0.78
Demand for care and nosocomial infection rate during the first influenza AH1N1 2009 virus outbreak at a referral hospital in Mexico City. Salud Publica Mex (2011) 0.78
Influenza: making privileged data public. Science (2009) 0.78
Method for evaluating quality of cultured neonatal pig Sertoli cells. Xenotransplantation (2005) 0.77
[Cytochrome P450 and NAT2 polymorphisms and drug metabolism in DOTS]. Rev Invest Clin (2008) 0.77
Clinical and Prognostic Factors Associated With Survival in Mexican Patients With Idiopathic Inflammatory Myopathies. J Clin Rheumatol (2016) 0.77
RBC membrane damage and decreased band 3 phospho-tyrosine phosphatase activity are markers of COPD progression. Front Biosci (Elite Ed) (2010) 0.76
Does anticoagulation in Eisenmenger syndrome impact long-term survival? Congenit Heart Dis (2012) 0.75
A 2-year-old girl positive for 2009 AH1N1 pandemic influenza. Ann Neurol (2011) 0.75
Steroids are a risk factor for Kaposi's sarcoma-immune reconstitution inflammatory syndrome and mortality in HIV infection. AIDS (2016) 0.75
Predictors of response to tumor necrosis factor-alpha blockers in ankylosing spondylitis. J Rheumatol (2005) 0.75
Panspermia--true or false? Lancet (2003) 0.75
Diminished humoral responses against and reduced gene expression levels of human endogenous retrovirus-K (HERV-K) in psoriasis. J Transl Med (2014) 0.75
Palatal Actinomycosis and Kaposi Sarcoma in an HIV-Infected Subject with Disseminated Mycobacterium avium-intracellulare Infection. Case Rep Med (2012) 0.75
Effect of histamine H3 receptor blockade on venous return and splanchnic hemodynamics in experimental bacteremia. Crit Care Med (2002) 0.75
Intralesional bevacizumab in patients with human immunodeficiency virus-associated Kaposi's sarcoma in the upper airway. Laryngoscope (2014) 0.75
[Modification of a hydraulic device for controlled banding of the trunk of the pulmonary artery in dogs]. Arch Cardiol Mex (2005) 0.75
[Impact of the deep breathing maneuver in the gas exchange in the subject with severe obesity and pulmonary arterial hypertension associated to Eisenmenger's syndrome]. Arch Cardiol Mex (2008) 0.75
[Severe right ventricular hypertension secondary to metastatic obstruction due to hepatocarcinoma]. Arch Cardiol Mex (2005) 0.75
[The response of the intensive care units during the influenza A H1N1 pandemic: the experience in Chiapas, Mexico]. Salud Publica Mex (2011) 0.75
[Capillary blood gas test usefulness to evaluate gas exchange with 21% and 100% of oxygen inspired fractions in subjects with stable cardiopulmonary disease at 2,240 meters above sea level]. Arch Cardiol Mex (2009) 0.75
Povidone-iodine against sodium hypochlorite as skin antiseptics in volunteers. Am J Infect Control (2010) 0.75
Cervical cancer and the HPV link: identifying areas for education in Mexico City's public hospitals. Salud Publica Mex (2006) 0.75
Endoscopic assessment of adenoid size is an indicator of tissue virologic response to highly active antiretroviral therapy. J Otolaryngol Head Neck Surg (2009) 0.75
Head and neck manifestations of the immune reconstitution syndrome in HIV-infected patients: a cohort study. Otolaryngol Head Neck Surg (2012) 0.75
First acute gout attacks commonly precede features of the metabolic syndrome. J Clin Rheumatol (2009) 0.75
The Pope, condoms, and the evolution of HIV. Lancet Infect Dis (2009) 0.75
Transfusion-associated HIV infection in Mexico related to paid blood donors; HIV epidemic. Int J STD AIDS (2004) 0.75